Erica Yeo

Miss Erica Yeo

Research Associate

Centre for Cancer Biology

College of Health


Dr Erica Yeo is an early career researcher in immunology with a focus on tumour immunology and cancer immunotherapy. Her research centres on understanding immune responses within the glioblastoma tumour microenvironment, with particular interest in CAR-T cell therapy and myeloid cell biology. She works extensively with primary human samples, integrating flow cytometry, imaging, and molecular profiling approaches to characterise immune cell phenotypes and function.

Year Citation
2024 Gargett, T., Truong, N. T. H., Gardam, B., Yu, W., Ebert, L. M., Johnson, A., . . . Brown, M. P. (2024). Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers. Journal for ImmunoTherapy of Cancer, 12(5), e008659-1-e008659-17.
DOI Scopus60 WoS57 Europe PMC53
2022 Gargett, T., Ebert, L. M., Truong, N. T. H., Kollis, P. M., Sedivakova, K., Yu, W., . . . Brown, M. P. (2022). GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer, 10(9), 1-15.
DOI Scopus106 WoS103 Europe PMC105
2021 Yeo, E. C. F., Brown, M. P., Gargett, T., & Ebert, L. M. (2021). The role of cytokines and chemokines in shaping the immune microenvironment of glioblastoma: implications for immunotherapy. Cells, 10(3, article no. 607), 1-25.
DOI Scopus84 WoS76 Europe PMC78
2021 Oksdath Mansilla, M., Salazar-Hernandez, C., Perrin, S. L., Scheer, K. G., Cildir, G., Toubia, J., . . . Gomez, G. A. (2021). 3D-printed microplate inserts for long term high-resolution imaging of live brain organoids. BMC biomedical engineering, 3(6), 1-14.
DOI Europe PMC25
2021 Lenin, S., Ponthier, E., Scheer, K. G., Yeo, E. C. F., Tea, M. N., Ebert, L. M., . . . Gomez, G. A. (2021). A drug screening pipeline using 2D and 3D patient-derived in vitro models for pre-clinical analysis of therapy response in glioblastoma. International Journal of Molecular Sciences, 22(9), 4322-1-4322-27.
DOI Scopus52 WoS48 Europe PMC55

Year Citation
2026 Brown, M. P., Le Blanc, A., Khan, S., Patel, S., Logan, J., Franze, O., . . . Gargett, T. (2026). Initial clinical and laboratory results of an ongoing dose escalation study of autologous GD2-CAR-T cells in patients with recurrent GD2-positive glioblastoma. Poster session presented at the meeting of CANCER RESEARCH. CA, San Diego: AMER ASSOC CANCER RESEARCH.
DOI

Connect With Me

External Profiles

Other Links